Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Spitz

Showing results (31-40 of 179) with videos related to

Pageof 18
Sort By:
Head & Neck|May 1, 1990
Salivary gland cancer and risk of subsequent skin cancerM R Spitz, J G Sider, G R Newell
Journal of the National Cancer Institute|November 21, 1990
Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignanciesS P Schantz, M R Spitz, T C Hsu
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 1991
Mutagen sensitivity: a biological marker of cancer susceptibilityT C Hsu, M R Spitz, S P Schantz
Princess Takamatsu Symposia|January 1, 1987
Epidemiologic similarities leading to etiologic hypothesesG R Newell, M R Spitz, D E Johnson
Cancer Research|September 15, 1996
Reduced DNA repair capacity in lung cancer patientsQ Wei, L Cheng, W K Hong, et al.
Cancer Letters|April 20, 2001
Cryopreserving whole blood for functional assays using viable lymphocytes in molecular epidemiology studiesL Cheng, L E Wang, M R Spitz, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Mutagen sensitivity as a marker of cancer susceptibilityM R Spitz, X Wu, H Jiang, et al.
Carcinogenesis|July 27, 2000
Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysisL Cheng, M R Spitz, W K Hong, et al.
Archives of Otolaryngology--Head & Neck Surgery|October 1, 1990
Salivary gland cancer. A case-control investigation of risk factorsM R Spitz, J J Fueger, H Goepfert, et al.
Anticancer Research|May 1, 1996
Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patientsB J Dave, S A Risin, M R Spitz, et al.
Pageof 18

Showing results (31-40 of 179) with videos related to

Sort By:
Pageof 18
Head & Neck|May 1, 1990
Salivary gland cancer and risk of subsequent skin cancerM R Spitz, J G Sider, G R Newell
Journal of the National Cancer Institute|November 21, 1990
Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignanciesS P Schantz, M R Spitz, T C Hsu
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 1991
Mutagen sensitivity: a biological marker of cancer susceptibilityT C Hsu, M R Spitz, S P Schantz
Princess Takamatsu Symposia|January 1, 1987
Epidemiologic similarities leading to etiologic hypothesesG R Newell, M R Spitz, D E Johnson
Cancer Research|September 15, 1996
Reduced DNA repair capacity in lung cancer patientsQ Wei, L Cheng, W K Hong, et al.
Cancer Letters|April 20, 2001
Cryopreserving whole blood for functional assays using viable lymphocytes in molecular epidemiology studiesL Cheng, L E Wang, M R Spitz, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Mutagen sensitivity as a marker of cancer susceptibilityM R Spitz, X Wu, H Jiang, et al.
Carcinogenesis|July 27, 2000
Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysisL Cheng, M R Spitz, W K Hong, et al.
Archives of Otolaryngology--Head & Neck Surgery|October 1, 1990
Salivary gland cancer. A case-control investigation of risk factorsM R Spitz, J J Fueger, H Goepfert, et al.
Anticancer Research|May 1, 1996
Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patientsB J Dave, S A Risin, M R Spitz, et al.
Pageof 18